证券之星消息，沃森生物(300142)02月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司九价HPV疫苗目前III期临床、数据统计、申报准备的最新节点是否顺利？预计提交上市申请的时间窗口与后续规划如何？相比同类产品的临床优势、产能规划、市场定位有哪些积极亮点？沃森生物回复：尊敬的投资者，您好！公司九价HPV疫苗目前处于III期临床研究阶段，公司在研疫苗的研发若有实质性和阶段性进展公司会及时披露，后续进展情况请关注公司披露的相关信息。谢谢！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.